Identification of linear polyubiquitin chain immunoreactivity in tau pathology of Alzheimer's disease

Neurosci Lett. 2019 Jun 11:703:53-57. doi: 10.1016/j.neulet.2019.03.017. Epub 2019 Mar 15.

Abstract

Characteristic neuropathological structures observed in Alzheimer's disease, such as neurofibrillary tangles and dystrophic neurites of senile plaques, are universally ubiquitinated. Eight linkage types of polyubiquitin chains are known, and each type of chain exerts different intracellular action. Among them, linear polyubiquitin chain was recently reported to be associated with the pathomechanism of neuronal cell death. We therefore generated a novel antibody that specifically recognizes linear polyubiquitin chain. We immunohistochemically examined the brains of patients with Alzheimer's disease. A subset of neurofibrillary tangles, dystrophic neurites of senile plaques, and neuropil threads were evident to be immunopositive for linear polyubiquitin chains, but their number was fewer than those recognized by the antibody against K48-linked polyubiquitin chains. Double immunofluorescence investigation showed that in certain neurofibrillary tangles, a part of K48-linked polyubiquitin-immunopositive structures were immunolabeled for linear polyubiquitin chains. Our results imply that linear polyubiquitination follows K48-linked polyubiquitination in abnormally accumulated tau proteins in Alzheimer's disease, and imply involvement in its neurodegeneration.

Keywords: Alzheimer; Immunohistochemistry; Linear polyubiquitination; Tau; Ubiquitin.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Alzheimer Disease / metabolism*
  • Antibodies, Monoclonal
  • Female
  • Hippocampus / metabolism
  • Humans
  • Immunohistochemistry
  • Male
  • Middle Aged
  • Polyubiquitin / immunology
  • Polyubiquitin / metabolism*
  • tau Proteins / metabolism*

Substances

  • Antibodies, Monoclonal
  • tau Proteins
  • Polyubiquitin